BIOMAT Database Logo BIOMAT Database Logo

Effect of liver damage on the pharmacokinetics of dexamethasone. 1994

S Kütemeyer, and T H Schürmeyer, and A von zur Mühlen
Abteilung klinische Endokrinologie, Medizinische Hochschule Hannover, Germany.

By measuring the pharmacokinetics of dexamethasone in 48 patients with various degrees of disturbances in liver function, we could demonstrate a decrease in the metabolic clearance of this steroid by 53% if the activity of the plasma cholinesterase was lowered to less than 2 kU/l. Results suggest that the dosage of dexamethasone given for diagnostic or therapeutic purpose needs to be adjusted in such patients.

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D002802 Cholinesterases Acylcholineacylhydrolase,Cholase,Cholinesterase
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Kütemeyer, and T H Schürmeyer, and A von zur Mühlen
The effect of dexamethasone on the pharmacokinetics of triazolam.
September 1998, Pharmacology & toxicology,
S Kütemeyer, and T H Schürmeyer, and A von zur Mühlen
[On the pharmacokinetics of sulfonamides in liver damage].
January 1968, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
S Kütemeyer, and T H Schürmeyer, and A von zur Mühlen
Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics.
February 1981, Journal of pharmacokinetics and biopharmaceutics,
S Kütemeyer, and T H Schürmeyer, and A von zur Mühlen
[Pharmacokinetics of pentobarbital in liver damage].
June 1977, Zeitschrift fur Gastroenterologie,
S Kütemeyer, and T H Schürmeyer, and A von zur Mühlen
Effect of liver dysfunction on cyclosporine pharmacokinetics.
February 1987, Transplantation proceedings,
S Kütemeyer, and T H Schürmeyer, and A von zur Mühlen
Pharmacokinetics of dexamethasone and its effect on adrenal gland function in the dog.
February 1983, American journal of veterinary research,
S Kütemeyer, and T H Schürmeyer, and A von zur Mühlen
Effect of liver failure on the pharmacokinetics of cyclophosphamide.
January 1984, European journal of clinical pharmacology,
S Kütemeyer, and T H Schürmeyer, and A von zur Mühlen
Pharmacokinetics of dexamethasone with pharmacokinetic/pharmacodynamic model of the effect of dexamethasone on endogenous hydrocortisone and cortisone in the horse.
February 2005, Journal of veterinary pharmacology and therapeutics,
S Kütemeyer, and T H Schürmeyer, and A von zur Mühlen
The effect of liver cirrhosis on the pharmacokinetics of phenprocoumon.
January 1984, European journal of clinical pharmacology,
S Kütemeyer, and T H Schürmeyer, and A von zur Mühlen
Effect of polyunsaturated fatty acids on dexamethasone-induced gastric mucosal damage.
February 2000, Prostaglandins, leukotrienes, and essential fatty acids,
Copied contents to your clipboard!